HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neonatal screening for cystic fibrosis.

Abstract
Two groups of patients with cystic fibrosis were compared. The screened group, detected with an improved neonatal screening assay for immunoreactive trypsin, developed fewer chest infections requiring treatment and gained more weight than the unscreened group. Early diagnosis by screening seems to affect early morbidity.
AuthorsF Bowling, G Cleghorn, A Chester, J Curran, B Griffin, J Prado, P Francis, R Shepherd
JournalArchives of disease in childhood (Arch Dis Child) Vol. 63 Issue 2 Pg. 196-8 (Feb 1988) ISSN: 1468-2044 [Electronic] England
PMID3348668 (Publication Type: Comparative Study, Journal Article)
Topics
  • Body Weight
  • Cystic Fibrosis (complications, prevention & control)
  • Follow-Up Studies
  • Humans
  • Infant, Newborn
  • Mass Screening
  • Queensland
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: